ACADIA Pharmaceuticals Inc.

Registered Members of Investor Village: Please make sure you are signed in to your Investor Village account to enjoy the full benefits of our service and avoid the MediaPass paywall. If the MediaPass offer page is blocking you, click the light blue "No thanks, take me back" link on the middle right side of the form to get to our home page where you can sign in by entering your Investor Village User Name and Password.

MediaPass subscribers: Please make sure you are logged in to your MediaPass subscription to bypass the paywall. You can do this by clicking the light blue "Already have a MediaPass account? Login here" link on the middle left side of the subscription offer form and then entering the email address and password you used when you first signed up with MediaPass.

For assistance call 888-222-7309 or email admin@investorvillage.com

ACAD / Message Board / Read Message

Keyword
Subject

Between			and
Rec'd By

Authored By
Minimum Recs

Msg 15693 of 16744 at 9/19/2019 5:11:09 PM by

In response to msg 15692 by Nazaretti	view thread

ACAD said in the conf call that ~67% of the DRP PhIII enrollees were ADP diagnosis.

That would be a fair assumption.

| More

Recs: 1 Views: 352


	About Us • Contact Us • Follow Us on Twitter • Members Directory • Help Center • Advertise Not a member yet? What are you waiting for? Create Account Want to contribute? Support InvestorVillage by donating © 2003-2019 Investorvillage.com. All rights reserved. User Agreement